The Effects of Fish Oil on Patients With Chronic Nonspecific Low Back Pain
CompletedNot applicableNCT02774109
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Objectives: To investigate the efficacy of omega-3 polyunsaturated fatty acids (PUFA) on patients with chronic nonspecific low back pain (NLBP). Methods and Materials: Twenty-nine patients with chronic NLBP were randomly divided into experimental and control groups. For 8 weeks, participants in the experimental group received omega-3 PUFA at 3000 mg/day plus physical therapy, while those in the control group received placebo plus physical therapy. The visual analog pain scale, pressure algometer, Biering-Sorenson test, Roland-Morris Low Back Pain and Disability Questionnaire (RMQ), and occupational burnout inventory (OBI) were used in assessments at baseline (T0) and after 4 (T1) and 8 weeks (T2). Serum erythrocyte sedimentation rate (ESR) and hypersensitive C-reactive protein (hs-CRP) were checked at baseline and T2.
Study details
- Official title
- The Effects of Fish Oil on Patients With Chronic Nonspecific Low Back Pain
- Conditions
- Interventions
- Dietary supplement: Fish oil
- Dietary supplement: Placebo
- Procedure: Hotpacking
- Procedure: Transcutaneous electrical nerve stimulation (TENS)
- Sponsor
- Chang Gung Memorial Hospital
- Start date
- 2016-12
- Primary completion
- 2017-11
- Sex
- All
- Age range
- from 20 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- Taiwan
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Male and female aged 20-50 * Low back pain duration over 3 months and pain intensity over 40mm when assessed with 100mm VAS Exclusion Criteria: * History of major trauma or surgery at back * Obvious spinal pathology on plain film (e.g. scoliosis, spondylosis, spondylolisthesis) * Not suitable for taking fish oil or receiving physical modality treatment * Having other inflammatory disease (e.g. rheumatic arthritis, endometriosis, ankylosing spondylitis, infection) * Pregnancy * Regularly taking fish oil or fatty fish more than 2 times per week * Having coagulopathy or currently taking anti-coagulation agent * Receiving oral or topical NSAID in the past one week * Taking oral corticosteroid in the past 6 weeks * Receiving local injection of corticosteroid or prolotherapy in the past 3 months
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02774109